Shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $604.67.
Several research firms recently commented on AXON. Robert W. Baird raised their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Needham & Company LLC reiterated a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd.
Check Out Our Latest Stock Report on AXON
Insider Buying and Selling
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of AXON. Fourth Dimension Wealth LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $30,000. Prestige Wealth Management Group LLC lifted its position in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth about $40,000. Brooklyn Investment Group acquired a new position in Axon Enterprise during the third quarter valued at approximately $41,000. Finally, Y.D. More Investments Ltd bought a new position in shares of Axon Enterprise in the fourth quarter valued at $45,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Axon Enterprise Trading Down 1.7 %
Shares of NASDAQ AXON opened at $558.41 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise has a one year low of $273.52 and a one year high of $715.99. The business has a 50-day moving average price of $592.10 and a two-hundred day moving average price of $539.60. The firm has a market capitalization of $42.79 billion, a PE ratio of 144.29, a PEG ratio of 5.17 and a beta of 1.12.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- How to Calculate Stock Profit
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Investing In Automotive Stocks
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- 3 Monster Growth Stocks to Buy Now
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.